Abstract
MSI-H/ dMMR is an actionable biomarker in the treatment of several tumors. Given data paucity, the study assessed the frequency of and testing patterns for MSI-H/dMMR across various solid tumors in a real-world community oncology setting in the US.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
